posted
LBTN just realeased their revenues over $2M for the first three quarters of 2006. There arn't too many stNov 7, 2006 8:31:00 AM RENO, NV -- (MARKET WIRE) -- 11/07/06 -- Lifeline Biotechnologies, Inc. (www.lbtn.com) (PINKSHEETS: LBTN) today announced that Jim Holmes, CEO and President of Lifeline Biotechnologies, Inc., was featured on MacReport.Net. In his interview, Mr. Holmes discussed the recent developments with the Company and the posted quarterly financial statements on www.lbti.com showing over $2 million in revenues.
Lifeline Biotechnologies, Inc. has partial ownership of Solos Endoscopy and is going to continue to assist in the development of the First Warning System. Mr. Holmes discussed that Solos Endoscopy has a long history in the medical field and has the necessary tools available to produce the First Warning System once it is ready to be released on the market.
"We are very pleased with the results from the recent sale of our medical technology to Solos Endoscopy and acquired interest in Trendsetter Solar Products. The previous twelve years, we have been a research and development company and are concentrating on acquiring additional medical products with existing sales. We look forward to an encouraging and successful future with additional acquisitions," stated Jim Holmes, CEO of Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies, Inc. recently announced that the Company has reported operating profits of $2,012,098 for the first three quarters of 2006. Lifeline Biotechnologies' unaudited financial statements also show revenues of $2.7 Million, which were generated by the sale of Lifeline's medical products to Solos Endoscopy and other operating sources.
To listen to the interview in its entirety, please visit: www.MacReport.net. ocks trading at their lows which can make that claim. Take a look .
IP: Logged |
Press Release Source: Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies, Inc. Reports Operating Profits in Excess of $2,000,000 for the First Three Quarters of 2006 Wednesday November 1, 8:31 am ET
RENO, NV--(MARKET WIRE)--Nov 1, 2006 -- Lifeline Biotechnologies, Inc. (Other OTC:LBTN.PK - News) today announced that the Company has reported operating profits of $2,012,098 for the first three quarters of 2006. Lifeline Biotechnologies' unaudited financial statements also show revenues of $2.7 Million, which were generated by the sale of Lifeline's medical products to Solos Endoscopy and other operating sources. Lifeline Biotechnologies received Solos Endoscopy (Other OTC:SLSE.PK - News) common stock in exchange for the Company's medical products line. Lifeline recently distributed approximately 13 million shares to qualified (record date 8/18/06) owners of LBTN common stock. Earlier this year, Lifeline Biotechnologies changed its business strategy to include opportunities beyond the medical industry and began to focus on acquiring interest in the Alternate Energy Field.
"This is an exciting day for our Company and our shareholders, as we realize a significant growth in profits, as a result of our years of hard work and commitment. We will continue to seek out revolutionary new medical and alternative energy companies that we can invest in and benefit from," stated Jim Holmes, CEO of Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies, Inc. recently announced that it received approximately 8.3 million shares of TrendSetter Solar Products (Other OTC:TSSP.PK - News) which represents more than $400,000 in total value which will be added to the company's balance sheet. The acquisition of TrendSetter Solar Products is part of Lifeline's strategy to increase shareholder value by improving its asset valuation and the potential of issuing dividends to its shareholders.
About Lifeline Biotechnologies, Inc.:
Lifeline Biotechnologies develops and acquires undervalued companies which have innovative technology in the medical, nutraceutical, and energy industries, to increase the growth of the Company. Lifeline Biotechnologies continues to seek out and capitalize on emerging technologies that will change the medical, nutraceutical, and energy community. More information is available at the company's website: www.lbtn.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Contact: CONTACT: Lifeline Biotechnologies, Inc. Investor Relations 407-884-0444 or 1-866-THE-APPLE
-------------------------------------------------------------------------------- Source: Lifeline Biotechnologies, Inc.
IP: Logged |
posted
Hi All! Has anyone been watching this today? Consistant trades of 9,000,000 shares through out the day. Same thing a few days ago. Is something brewing? Anyone have any insight?
in my experience when i see many 9m trades it means dilution
quote:Originally posted by Justbob286: Hi All! Has anyone been watching this today? Consistant trades of 9,000,000 shares through out the day. Same thing a few days ago. Is something brewing? Anyone have any insight?
Looks to me someone is buying shares at the lowest possible pps?
I'm VERY new with this so any feedback would be great. Why would they dilute at low levels? The only reason I can see would be that they are giving up at these prices and are going to R/S to lower shares and increase pps. Sound reasonable? Or, am I looking at this completely wrong? lol THANKS
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Smile]](smile.gif)
